Clinical Trials Directory

Trials / Completed

CompletedNCT04760405

The TOTOM Trial: Tai Chi to Optimize Transplant Outcomes for Multiple Myeloma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Arizona · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The current proposal aims to test the feasibility of immune function analysis for Tai Chi Easy (TCE) intervention in multiple myeloma (MM) patients undergoing autologous stem cell transplantation (ASCT) with concurrent exploration of health related quality of life (HRQOL).

Detailed description

The current proposal aims to test the feasibility of immune function analysis for TCE intervention in MM patients undergoing ASCT with concurrent exploration of HRQOL. The data obtained from this trial will provide supporting data for a future randomized clinical trial evaluating the impact of TCE on immune function (incidence of ASCT related infectious complications, natural killer cell phenotype and activity, and myeloma remission rate (clonal plasma cell % at day 100, minimal residual disease (MRD)), with the evaluation of efficacy on improving HRQOL during ASCT. Successful completion of this CROC project will provide necessary data to support future grant applications, in particular the feasibility of immunoassay evaluation of MM patients undergoing ASCT.

Conditions

Interventions

TypeNameDescription
OTHERTai Chi EasyPatients will receive two 30-minute small group training sessions (Via Zoom) within 7 days of their scheduled transplant. After the training has been completed the participant will be provided with written (via manual) and electronic (DVD, MP3 file download) materials to continue with self-direct practice throughout the duration of the study.

Timeline

Start date
2021-03-11
Primary completion
2023-11-28
Completion
2023-11-28
First posted
2021-02-18
Last updated
2024-08-16

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04760405. Inclusion in this directory is not an endorsement.